Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis-Reference-Cited by-同舟云学术

Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis

Published:2020-04 Issue:1 Volume:157 Page:209-213
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Ghirardi V.,Moruzzi M.C.,Bizzarri N.,Vargiu V.,D'Indinosante M.,Garganese G.,Pasciuto T.,Loverro M.,Scambia G.,Fagotti A.

Funder

Italian Society of Obstetrics and Gynecology

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference34 articles.

1. Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining ‘optimal’ residual disease;Chang;Gynecol. Oncol.,2012

2. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J. Clin. Oncol.,2002

3. Long follow-up and prognostic factor analysis in advanced ovarian carcinoma: the gynecologic oncology group experience;Omura;J. Clin. Oncol.,1991

4. Role of surgical outcome as prognostic factor randomized phase 3 multicenter trials;Bois;Cancer,2009

5. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?;Sioulas;Gynecol. Oncol.,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy;International Journal of Gynecologic Cancer;2024-08-07

2. Characteristics, Treatment Patterns and Survival of International Federation of Gynecology and Obstetrics Stage IV Epithelial Ovarian Cancer—A Population-Based Study;Cancers;2023-11-30

3. Application of artificial intelligence in CT and MR imaging of ovarian cancer;Chinese Journal of Academic Radiology;2023-11-30

4. Change of Fagotti score is associated with outcome after neoadjuvant chemotherapy for ovarian cancer;International Journal of Gynecologic Cancer;2023-08-10

5. NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models;ACS Applied Materials & Interfaces;2023-06-29